Goncalo de Vasconcelos, CEO of equity funding platform SyndicateRoom, explains how investors can gain exposure to smaller companies developing medical innovations via crowdfunding.
Medical technology is the investment story of the moment. It is 15 years since the ‘eureka’ moment when the entire human genome was mapped for the first time, and the practical applications made possible by that work are transforming people’s lives. It took time to commercialise genomics and related technologies, but the scale of the opportunity is now unprecedented. To see why, consider the $3bn cost of that first mapping project. Today, by contrast, table-top gene sequencing equipment that does the same job costs less than $1,000. At that cost, even the most small-scale ventures (sp...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
